Mechanisms of action and synergies of a novel lipid IV A biosynthesis inhibitor
Preprint
Abstract
The development of novel antimicrobials provides additional treatment options for infectious diseases, including antimicrobial resistant infections. There are many hurdles to antimicrobial development and identifying an antimicrobial’s mechanism of action is a crucial step in progressing candidate molecules through the drug discovery pipeline. We used the genome wide screening method TraDIS- Xpress to identify genes in two model Gram-negative bacteria that affected sensitivity to three analogues of a novel antimicrobial compound (OPT-2U1). TraDIS- Xpress identified that all three analogues targeted the lipid IV A biosynthetic pathway in E. coli and Salmonella Typhimurium. Specifically, we determined that the antimicrobial target was likely to be LpxD, and validated this by finding a 5 log 2 -fold increase in the MIC of the OPT-2U1 analogues in E. coli when lpxD was overexpressed. Synergies were identified between OPT-2U1 analogues combined with rifampicin or colistin, to varying strengths, in both E. coli and S . Typhimurium. LPS composition was a likely reason for differences between E. coli and S.Typhimurium, as perturbation of LPS synthesis affected synergy between antibiotics and OPT-2U1 analogues. Finally, genes involved in ATP synthesis and membrane signalling functions were also found to affect the synergy between colistin and OPT-2U1 analogues. TraDIS- Xpress has proven a powerful tool to rapidly assay all genes (and notably, essential genes) within a bacterium for roles in dictating antimicrobial sensitivity. This study has confirmed the predicted target pathway of OPT-2U1 and identified synergies which could be investigated for development of novel antimicrobial formulations. Data Summary: Nucleotide sequence data supporting the analysis in this study has been deposited in ArrayExpress under the accession number E-MTAB-13250. The authors confirm all supporting data, code and protocols have been provided within the article or through supplementary data files.Keywords
This publication has 17 references indexed in Scilit:
- Lipopolysaccharide as an antibiotic targetBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2023
- Comparison of the genetic basis of biofilm formation between Salmonella Typhimurium and Escherichia coliMicrobial Genomics, 2022
- Chemical biology-whole genome engineering datasets predict new antibacterial combinationsMicrobial Genomics, 2021
- Exposure of Salmonella biofilms to antibiotic concentrations rapidly selects resistance with collateral tradeoffsnpj Biofilms and Microbiomes, 2021
- A genome-wide analysis of Escherichia coli responses to fosfomycin using TraDIS-Xpress reveals novel roles for phosphonate degradation and phosphate transport systemsJournal of Antimicrobial Chemotherapy, 2020
- Structural and Biological Basis of Small Molecule Inhibition of Escherichia coli LpxD Acyltransferase Essential for Lipopolysaccharide BiosynthesisACS Infectious Diseases, 2019
- Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysisThe Lancet Infectious Diseases, 2019
- The TraDIS toolkit: sequencing and analysis for dense transposon mutant librariesBioinformatics, 2016
- Construction of Escherichia coli K‐12 in‐frame, single‐gene knockout mutants: the Keio collectionMolecular Systems Biology, 2006
- The firA gene of Escherichia coli encodes UDP-3-O-(R-3-hydroxymyristoyl)-glucosamine N-acyltransferase. The third step of endotoxin biosynthesis.Journal of Biological Chemistry, 1993